Company Filing History:
Years Active: 1997-2005
Title: David E Burstein: Innovator in Cancer Diagnosis
Introduction
David E Burstein is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer diagnosis, holding a total of 3 patents. His work focuses on innovative methods for distinguishing between various types of carcinomas, which can greatly enhance diagnostic accuracy.
Latest Patents
One of Burstein's latest patents is titled "Differential diagnosis of cancer and other conditions based on expression of p63." This invention relates to methods of distinguishing among various types of differentiated and undifferentiated epithelial carcinomas, as well as non-epithelial carcinomas, by detecting the presence of p63 nucleic acid or protein expression. The invention also provides methods for detecting p63 nucleic acids and proteins, along with methods for diagnosing and treating certain tumors based on whether the tumors express p63. Another significant patent is the "Highly sensitive immunocytochemical method for diagnosis of malignant." This patent discloses a method of detecting malignancy in a body cavity effusion. It also includes methods for distinguishing a benign hyperplastic lymph node from a lymph node involved by low-grade follicular lymphoma, as well as distinguishing a benign tumor from a malignant tumor that overexpresses GLUT-1.
Career Highlights
Throughout his career, Burstein has worked with prestigious institutions such as Mount Sinai School of Medicine and The Mount Sinai Medical Center. His experience in these organizations has allowed him to develop and refine his innovative diagnostic methods.
Collaborations
One of Burstein's notable collaborators is Richard S Haber. Their partnership has contributed to advancements in cancer diagnosis and treatment methodologies.
Conclusion
David E Burstein's contributions to cancer diagnosis through his innovative patents highlight his role as a significant inventor in the medical field. His work continues to influence the way cancer is diagnosed and treated, showcasing the importance of innovation in healthcare.